Companies research board
Displaying 901 - 1000 of 1172![[current-page:title] logo](/sites/default/files/styles/thumbnail/public/default_images/_no-logo.png?itok=xgKd-YA_){kind=logo}
World's leading materials and life sciences research breakthrough analytical tools company.
Biotechnology company developing and commercializing the world's first protein microarrays.
Based on the expertise of Professor Peter Jenner, one of the world's leading authorities on neuro-degenerative diseases.
A biotechnology company using non-traditional approaches to develop novel therapeutics.
CRTH2 antagonists for the treatment of severe asthma and COPD. Signed a subcontracting agreement with Argenta.
Discovering a new class of host-targeted therapies that pathogen independently treat
QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide.
A company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology.
Computer-Assisted Drug Design and Computer-Assisted Molecular Modeling solutions company based on the increased accuracy & power of quantum mechanics.
The development and manufacture of a diagnostic instrument for the point of care measurement of HbA1C.
A biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of osteoporosis
Professional services to the Biotech, Medical Device, and Pharmaceutical.
Developer of a proprietary platform based on a new therapeutic approach to selectively up-regulating the expression of genes.
Biotechnology company for a protein involved in a critical pathway for cancer development.
A biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer.
Neurotrophic factors company for nerve repair and regeneration.
Biopharmaceutical company engaged in the design, research and development of novel peptides targeted at diseases with unmet medical needs.
Developer of screening/diagnostic tools for the early detection of viral diseases and cancers.
Developing processes to make high-value known chemicals derived from renewable bio sources that have both financial and green advantages
Developing new technologies, products and procedures aimed at the correction of presbyopia.
An ophthalmic biopharmaceutical company developing fenretinide (RT-101) for the treatment of age-related macular degeneration (AMD).
Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases
Acquisition of royalty interests in leading pharmaceutical and biotechnology products and holding them as part of a diversified portfolio
Developer of a unique (patent pending) magnetic cell selection technology.
Provider of services that address late stage preclinical development of therapeutics and devices.
Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs.
Pioneering the development of novel, fast and inexpensive immunoassays that will enable routine blood level monitoring of anti-cancer drugs
Online marketplace for scientific collaboration where researchers can order experiments from the world's best laboratories.
A biotechnology company advancing a broad pipeline of antibody-based therapies
A biotechnology company developing a new class of synthetic nanoparticle vaccines.
Develops implantable and permanently-antimicrobial surface technology that is incorporated into medical devices
Formed to commercialize new diagnostic tests for the early detection of cervical cancer caused by HPV infection and chronic kidney disease
Develop diagnostic tests for early prediction of preterm birth, preeclampsia and other pregnancy complications.
Provider of biological products for the global life sciences industry
A biopharmaceutical company which aimed to develop a pipeline of innovative, proprietary products to address unmet medical needs in dermatology.